FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax

Summary

Moderna's mRNA flu vaccine has received FDA approval, though the article notes that regulatory clearance represents only the initial step, with strain selection timing and market skepticism toward mRNA technology potentially limiting commercial impact.